The data was compiled using survey that polled the general public, conducted by The Reputation Institute.
Here are the 10 companies, according to Forbes:
1. AbbVie: 74.5
2. Novo Nordisk: 74
3. Takeda Pharmaceuticals: 73.8
4. Roche: 73.4
5. Janssen Pharmaceuticals: 72.5
6. Gilead Sciences: 72.4
7. Bayer: 72.3
8. Merck Sharp & Dohme: 72.2
9. Sanofi: 72
10. Eli Lilly: 71.9
More articles on improving health:
TJR volume positively impacts hospital performance under CMS quality metrics — 3 insights
The Joint Commission awards 3 John M. Eisenberg Safety and Quality Awards
Safety culture expert: 3 things to do instead of making accreditation reports public
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.